Shijiazhuang Yiling Pharmaceutical Co., Ltd. (SHE:002603)
China
· Delayed Price · Currency is CNY 14.18
-0.06 (-0.42%)
Feb 21, 2025, 3:04 PM CST
SHE:002603 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Feb '25 Feb 20, 2025 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Market Capitalization | 23,691 | 38,543 | 50,054 | 32,746 | 30,365 | 14,801 | Upgrade
|
| Market Cap Growth | -23.19% | -23.00% | 52.86% | 7.84% | 105.15% | 17.30% | Upgrade
|
| Enterprise Value | 24,047 | 38,844 | 48,806 | 32,890 | 28,787 | 13,533 | Upgrade
|
| Last Close Price | 14.18 | 22.64 | 28.81 | 18.63 | 16.71 | 8.09 | Upgrade
|
| PE Ratio | 159.55 | 28.50 | 21.18 | 24.37 | 24.91 | 24.40 | Upgrade
|
| Forward PE | 18.08 | 16.45 | 27.48 | 15.62 | 26.15 | 20.63 | Upgrade
|
| PS Ratio | 2.92 | 3.74 | 3.99 | 3.24 | 3.46 | 2.54 | Upgrade
|
| PB Ratio | 2.06 | 3.37 | 4.58 | 3.61 | 3.40 | 1.86 | Upgrade
|
| P/TBV Ratio | 2.82 | 3.64 | 4.90 | 3.89 | 3.60 | 1.98 | Upgrade
|
| P/FCF Ratio | - | - | 15.29 | - | 68.79 | - | Upgrade
|
| P/OCF Ratio | 90.28 | 247.93 | 14.35 | 61.94 | 19.14 | 214.74 | Upgrade
|
| EV/Sales Ratio | 2.97 | 3.76 | 3.89 | 3.25 | 3.28 | 2.32 | Upgrade
|
| EV/EBITDA Ratio | 31.15 | 18.05 | 14.82 | 17.58 | 16.99 | 14.86 | Upgrade
|
| EV/EBIT Ratio | 159.35 | 24.08 | 17.10 | 21.66 | 20.18 | 20.79 | Upgrade
|
| EV/FCF Ratio | -8137.25 | - | 14.91 | - | 65.22 | - | Upgrade
|
| Debt / Equity Ratio | 0.11 | 0.12 | 0.08 | 0.14 | 0.03 | 0.01 | Upgrade
|
| Debt / EBITDA Ratio | 1.67 | 0.66 | 0.26 | 0.65 | 0.16 | 0.05 | Upgrade
|
| Debt / FCF Ratio | - | - | 0.27 | - | 0.61 | - | Upgrade
|
| Asset Turnover | 0.48 | 0.62 | 0.86 | 0.83 | 0.85 | 0.66 | Upgrade
|
| Inventory Turnover | 1.86 | 1.98 | 2.47 | 2.27 | 2.23 | 1.76 | Upgrade
|
| Quick Ratio | 1.02 | 0.84 | 0.95 | 1.15 | 1.49 | 4.28 | Upgrade
|
| Current Ratio | 1.57 | 1.47 | 1.50 | 1.89 | 2.44 | 6.28 | Upgrade
|
| Return on Equity (ROE) | 1.20% | 12.02% | 23.57% | 14.91% | 14.40% | 7.77% | Upgrade
|
| Return on Assets (ROA) | 0.55% | 6.05% | 12.20% | 7.78% | 8.67% | 4.62% | Upgrade
|
| Return on Capital (ROIC) | 0.72% | 8.18% | 16.14% | 9.74% | 10.37% | 5.23% | Upgrade
|
| Return on Capital Employed (ROCE) | 1.19% | 12.87% | 24.83% | 15.27% | 15.41% | 7.88% | Upgrade
|
| Earnings Yield | 0.63% | 3.51% | 4.72% | 4.10% | 4.01% | 4.10% | Upgrade
|
| FCF Yield | -0.01% | -0.40% | 6.54% | -0.44% | 1.45% | -2.60% | Upgrade
|
| Dividend Yield | 2.12% | 1.33% | 1.74% | 1.61% | 4.27% | 1.77% | Upgrade
|
| Payout Ratio | 482.97% | 64.54% | 11.96% | 90.79% | 20.03% | 19.75% | Upgrade
|
| Buyback Yield / Dilution | 0.01% | 0.01% | -0.01% | 0.00% | -0.35% | 0.79% | Upgrade
|
| Total Shareholder Return | 2.12% | 1.33% | 1.73% | 1.61% | 3.93% | 2.55% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.